Aspirin Use May Decrease Ventilation, ICU admission and Death in COVID-19 Patients

George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients. Final results indicating the lung protective effects of aspirin were published today in Anesthesia & Analgesia.

Read more

Most Patients Find Teledermatology Appointments Suitable Alternative to Office Visits

The majority of dermatology patients surveyed find telehealth appointments to be a suitable alternative to in-person office visits, according to a survey study published in Journal of Drugs in Dermatology from researchers at the George Washington University.

Read more

Benefits of High-dose Blood Thinners in COVID-19 Patients Remain Unclear

While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be ineffective and even harmful. 

Read more

Blood Test May Point to Patients at Higher Risk for COVID-19 Deterioration, Death

George Washington University researchers found five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients. Published in Future Medicine, these findings will help physicians better predict outcomes for COVID-19 patients in the U.S.

Read more

Microbiome Provides New Clues to Determining Development of Colon Cancer

Findings showcasing a connection between bacteria in the microbiome and colon cancer, which may be used to screen younger populations at risk, were published in the journal Gastroenterology by researchers from the George Washington University.

Read more